RADNOR, Pa., March 21, 2016 -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has recently expanded its investigation of Theranos, Inc. (“Theranos” or the “Company”) on behalf of the Company’s investors.
Theranos investors who wish to discuss this investigation and/or their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299 – 7706 or at [email protected]. For additional information about the investigation, or to request information about the investigation online, please visit www.ktmc.com/theranos-inc.
On January 27, 2016, The Wall Street Journal reported that “Federal inspectors found ‘deficient practices’ at a Theranos Inc. laboratory that ‘pose immediate jeopardy to patient health and safety.’” The article further reported that the recent inspection had “uncovered five major infractions that violate the federal law governing clinical labs,” and that one infraction was defined “as a situation ‘likely to cause, at any time, serious injury or harm, or death, to individuals served by the laboratory or to the health and safety of the general public.’”
Most recently, on March 8, 2016, The Wall Street Journal reported that a “federal inspection report said a Theranos Inc. laboratory ran an important blood test on 81 patients in a six-month period despite erratic results from quality-control checks meant to ensure the test’s accuracy,” and that “[i]nnacurate results from the test can be especially serious for patients.” Citing people familiar with the inspection report, The Wall Street Journal further reported that “the report also found that the lab’s director didn’t have responsibility for the lab’s quality control program and the lab’s quality-control manager was unqualified.”
Theranos investors who wish to discuss this investigation and/or their legal options are encouraged to contact Kessler Topaz Meltzer & Check, LLP (D. Seamus Kaskela, Esq. or Adrienne O. Bell, Esq.) at (888) 299 – 7706 or at [email protected]. Kessler Topaz Meltzer & Check prosecutes class actions in state and federal courts throughout the country. Kessler Topaz Meltzer & Check is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about Kessler Topaz Meltzer & Check please visit www.ktmc.com.
CONTACT: Kessler Topaz Meltzer & Check, LLP D. Seamus Kaskela, Esq. Adrienne O. Bell, Esq. 280 King of Prussia Road Radnor, PA 19087 (888) 299 - 7706 (610) 667 - 7706 [email protected]


Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 



